Literature DB >> 31949734

Correlation of LARP1 and E-cadherin expression with prognosis of intrahepatic cholangiocarcinoma.

Fei Jiang1, De-Bao Fang1, Jie Lin1, Qiang Chen1, Li-Xin Zhu1, Hong-Zhu Yu1.   

Abstract

OBJECTIVE: The abnormal expression of LARP1 and E-cadherin (E-cad) is related to tumor occurrence and metastasis. Our study analyzed the expression of LARP1 and E-cad in intrahepatic cholangiocarcinoma (ICC) and investigated the prognostic value of the two proteins.
METHODS: Immunohistochemistry was performed to detect the expression of LARP1 and E-cad in 50 ICC clinical specimens with adjacent normal tissues and 20 normal bile duct tissues. In situ hybridization was performed to analyze the expression of LARP1 mRNA in all the specimens.
RESULTS: LARP1 protein and mRNA expression levels in ICC tumor tissues were significantly higher compared with corresponding adjacent normal tissues and normal epithelial tissues (P<0.01). E-cad protein expression in ICC tumor tissues was remarkably lower than that of the adjacent normal tissues and benign bile duct tissues (P<0.01). Correlation analysis demonstrated that LARP1 and E-cad expression levels were significantly related with the tumor-node-metastasis staging and lymph node metastasis (P<0.01), while no correlation was observed with patient age, gender, and tumor size. Moreover, Spearman rank correlation test revealed that LARP1 expression was negatively related to E-cad (P<0.05). More importantly, the patients with higher LARP1 expression or lower E-cad expression had a shorter overall survival postoperatively than those with LARP1 lower expression or E-cad higher expression. Multivariate analysis demonstrated that LARP1 and E-cad were both considered as important prognostic factors for survival time.
CONCLUSION: These findings suggest that the abnormal expression of LARP1 and E-cad showed a close relationship with the occurrence and metastasis of ICC, leading to poor prognosis indirectly. IJCEP
Copyright © 2018.

Entities:  

Keywords:  E-cadherin; LARP1; intrahepatic cholangiocarcinoma

Year:  2018        PMID: 31949734      PMCID: PMC6962836     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  18 in total

1.  An analysis of 680 cases of cholangiocarcinoma from 8 hospitals.

Authors:  Xiao-Fang Liu; Xian-Ting Zhou; Sheng-Quan Zou
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2005-11

2.  The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration.

Authors:  Carla Burrows; Normala Abd Latip; Sarah-Jane Lam; Lee Carpenter; Kirsty Sawicka; George Tzolovsky; Hani Gabra; Martin Bushell; David M Glover; Anne E Willis; Sarah P Blagden
Journal:  Nucleic Acids Res       Date:  2010-04-29       Impact factor: 16.971

3.  Clinicopathologic features, diagnosis and surgical treatment of intrahepatic cholangiocarcinoma in 104 patients.

Authors:  Xiao-Hui Fu; Zhao-Hui Tang; Ming Zong; Guang-Shun Yang; Xiao-Ping Yao; Meng-Chao Wu
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-05

4.  Trans-bonded pairs of E-cadherin exhibit a remarkable hierarchy of mechanical strengths.

Authors:  E Perret; A Leung; H Feracci; E Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205

5.  Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer.

Authors:  Michael K Wendt; Molly A Taylor; Barbara J Schiemann; William P Schiemann
Journal:  Mol Biol Cell       Date:  2011-05-25       Impact factor: 4.138

6.  LARP1 predict the prognosis for early-stage and AFP-normal hepatocellular carcinoma.

Authors:  Chan Xie; Li Huang; Shibin Xie; Dongying Xie; Genlin Zhang; Peipei Wang; Liang Peng; Zhiliang Gao
Journal:  J Transl Med       Date:  2013-10-26       Impact factor: 5.531

7.  The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer.

Authors:  Thomas G Hopkins; Manuela Mura; Hiba A Al-Ashtal; Roni M Lahr; Normala Abd-Latip; Katrina Sweeney; Haonan Lu; Justin Weir; Mona El-Bahrawy; Jennifer H Steel; Sadaf Ghaem-Maghami; Eric O Aboagye; Andrea J Berman; Sarah P Blagden
Journal:  Nucleic Acids Res       Date:  2015-12-29       Impact factor: 16.971

8.  Selective serotonin reuptake inhibitor, fluoxetine, impairs E-cadherin-mediated cell adhesion and alters calcium homeostasis in pancreatic beta cells.

Authors:  Huang-Yu Chang; Shu-Ling Chen; Meng-Ru Shen; Mei-Lang Kung; Lee-Ming Chuang; Yun-Wen Chen
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

9.  Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.

Authors:  Ling Ye; Sheng-Tao Lin; Yu-Shuai Mi; Yuan Liu; Yang Ma; Hui-Min Sun; Zhi-Hai Peng; Jun-Wei Fan
Journal:  Tumour Biol       Date:  2016-09-10

10.  Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.

Authors:  Eri Samukawa; Shintaro Fujihara; Kyoko Oura; Hisakazu Iwama; Yoshimi Yamana; Tomoko Tadokoro; Taiga Chiyo; Kiyoyuki Kobayashi; Asahiro Morishita; Mai Nakahara; Hideki Kobara; Hirohito Mori; Keiichi Okano; Yasuyuki Suzuki; Takashi Himoto; Tsutomu Masaki
Journal:  Int J Oncol       Date:  2017-10-23       Impact factor: 5.650

View more
  4 in total

1.  Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures.

Authors:  Fei Lu; Jingyan Gao; Yu Hou; Ke Cao; Yaoxiong Xia; Zhengting Chen; Hui Yu; Li Chang; Wenhui Li
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

2.  Circ_0047921 acts as the sponge of miR-1287-5p to stimulate lung cancer progression by regulating proliferation, migration, invasion, and glycolysis of lung cancer cells.

Authors:  Yuehua Xiao; Shequn Gu; Wenxiu Yao; Ling Qin; Jihui Luo
Journal:  World J Surg Oncol       Date:  2022-04-02       Impact factor: 2.754

3.  N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the Pancreas.

Authors:  Tiemo S Gerber; Benjamin Goeppert; Anne Hausen; Hagen R Witzel; Fabian Bartsch; Mario Schindeldecker; Lisa-Katharina Gröger; Dirk A Ridder; Oscar Cahyadi; Irene Esposito; Matthias M Gaida; Peter Schirmacher; Peter R Galle; Hauke Lang; Wilfried Roth; Beate K Straub
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

4.  microRNA-206 Suppresses Cholangiocarcinoma Cell Growth and Invasion by Targeting Jumonji AT-Rich Interactive Domain 2.

Authors:  Chunying Xie; Zhenxing Huang; Zhaohui Huang; Xue Zhang; Siyuan Lou
Journal:  Dig Dis Sci       Date:  2021-07-08       Impact factor: 3.487

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.